Common Contracts
9 similar Purchase Agreement contracts by Accelerate Diagnostics, Inc, B2gold Corp, CSG Systems International Inc, others
OPKO Health, Inc. Purchase AgreementPurchase Agreement • January 9th, 2024 • Opko Health, Inc. • Pharmaceutical preparations • New York
OPKO Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $200,000,000 aggregate principal amount of its 3.75% Convertible Senior Notes due 2029 (the “Firm Securities”) and, at the option of the Initial Purchasers, up to an additional $30,000,000 aggregate principal amount of its 3.75% Convertible Senior Notes due 2029 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 3.75% Convertible Senior Notes due 2029 granted to the Initial Purchasers in Section 2 hereof. The Firm Securities and the Option Securities are herein referred to as the “Securities.” Subject to the terms of the Indenture (as defined below), the Securities will be convertible into (i) before the Company satisfies the Share Reservation Condition (as herein
PURCHASE AGREEMENT United States Steel Corporation $300,000,000 5.00% Senior Convertible Notes due 2026Purchase Agreement • October 21st, 2019 • United States Steel Corp • Steel works, blast furnaces & rolling mills (coke ovens) • New York
United States Steel Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom Goldman Sachs & Co. LLC and Barclays Capital Inc. are acting as representatives (the “Representatives”), $300,000,000 aggregate principal amount of its 5.00% Senior Convertible Notes due 2026 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $50,000,000 principal amount of 5.00% Senior Convertible Notes due 2026 (the “Option Securities”). The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underlying Securities”) of common stock, par value $1.00 per share, of the Company (the “Common Stock”). The Securities will be issued pursuant to an indenture to be dated as of October 21, 2019 (the “Indenture”) between the Company and The Bank of New York Mel
Accelerate Diagnostics, Inc. Purchase AgreementPurchase Agreement • March 28th, 2018 • Accelerate Diagnostics, Inc • Laboratory analytical instruments • New York
Accelerate Diagnostics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $150,000,000 aggregate principal amount of its 2.50% Convertible Senior Notes due 2023 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $22,500,000 aggregate principal amount of its 2.50% Convertible Senior Notes due 2023 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such Option Securities granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares (the “Underlying Securities”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), or a
Invacare Corporation $105,000,000 4.50% Convertible Senior Notes due 2022 Purchase AgreementPurchase Agreement • June 14th, 2017 • Invacare Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
Invacare Corporation, an Ohio corporation (the “Company”), proposes to issue and sell to Goldman Sachs & Co. LLC (the “Initial Purchaser”) $105,000,000 principal amount of its 4.50% Convertible Senior Notes due 2022 (the “Underwritten Securities”) and, at the option of the Initial Purchaser, up to an additional $15,000,000 principal amount of its 4.50% Convertible Senior Notes due 2022 solely to cover over-allotments (the “Option Securities”) if and to the extent that the Initial Purchaser shall have determined to exercise the option to purchase such 4.50% Convertible Senior Notes due 2022 granted to the Initial Purchaser in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, common shares of the Company, without par value (the “Common Shares”), or a combination of cash and Common Shares, at the option of the Company on the terms, and subject to the conditions, set forth in the
KNOWLES CORPORATION Purchase AgreementPurchase Agreement • May 4th, 2016 • Knowles Corp • Household audio & video equipment • New York
Knowles Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $150,000,000 principal amount of its 3.25% Convertible Senior Notes due 2021 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $22,500,000 principal amount of its 3.25% Convertible Senior Notes due 2021 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 3.25% Convertible Senior Notes due 2021 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities.” The Securities will be convertible into cash, shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), or a combination of cash and Common Stock,
PURCHASE AGREEMENTPurchase Agreement • March 15th, 2016 • CSG Systems International Inc • Services-computer processing & data preparation • New York
CSG Systems International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $200,000,000 principal amount of its 4.25% Senior Convertible Notes due 2036 (the “Firm Securities”) and, at the option of the Initial Purchasers, up to an additional $30,000,000 principal amount of its 4.25% Senior Convertible Notes due 2036 (the “Option Securities”) solely to cover over-allotments, if any, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 4.25% Senior Convertible Notes due 2036 granted to the Initial Purchasers solely to cover over-allotments, if any, in Section 2 hereof. The Firm Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares (the “Underlying Securities”) of common s
B2GOLD CORP. Purchase AgreementPurchase Agreement • August 23rd, 2013 • B2gold Corp • Gold and silver ores • New York
As Representatives of the several Initial Purchasers listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179
Purchase AgreementPurchase Agreement • August 20th, 2013 • New York
B2Gold Corp., a company amalgamated under the laws of British Columbia (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $225,000,000 principal amount of its 3.25% Convertible Senior Subordinated Notes due 2018 (the “Underwritten Securities”) and at the option of the Initial Purchasers, up to an additional $33,750,000 principal amount of its 3.25% Convertible Senior Subordinated Notes due 2018 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 3.25% Convertible Senior Subordinated Notes due 2018 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities. The Securities will be convertible into common shares of the Company (the “Common Shares”), without par value
WRIGHT MEDICAL GROUP, INC. Purchase AgreementPurchase Agreement • August 28th, 2012 • Wright Medical Group Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
Wright Medical Group, Inc., a Delaware corporation (herein called the “Company” which term shall include its direct and indirect subsidiaries unless the context otherwise requires), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $260,000,000 principal amount of its 2.00% Cash Convertible Senior Notes due 2017 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $40,000,000 principal amount of its 2.00% Cash Convertible Senior Notes due 2017 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 2.00% Cash Convertible Senior Notes due 2017 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be issued pursuant
